Cubist Systematic Strategies, LLC Genmab A/S Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Genmab A/S stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 1,258,143 shares of GMAB stock, worth $25.6 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,258,143

Previous 592,250 112.43%

Holding current value

$25.6 Million

Previous $12.4 Million 99.3%

% of portfolio

0.16%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$18.69 - $24.14 $12.4 Million - $16.1 Million	665,893 Added 112.43%	1,258,143 $24.6 Million
Q4 2024 Feb 14, 2025	BUY	$20.02 - $24.15 $11.9 Million - $14.3 Million	592,250 New	592,250 $12.4 Million
Q2 2024 Aug 14, 2024	BUY	$25.13 - $30.27 $3.66 Million - $4.41 Million	145,689 Added 109.66%	278,541 $7 Million
Q1 2024 May 15, 2024	SELL	$26.43 - $32.77 $2.1 Million - $2.61 Million	-79,594 Reduced 37.47%	132,852 $3.97 Million
Q4 2023 Feb 14, 2024	BUY	$27.94 - $35.44 $5.08 Million - $6.44 Million	181,699 Added 590.95%	212,446 $6.76 Million
Q3 2023 Nov 14, 2023	SELL	$35.27 - $42.24 $2.04 Million - $2.45 Million	-57,928 Reduced 65.33%	30,747 $1.08 Million
Q2 2023 Aug 14, 2023	BUY	$37.4 - $42.94 $3.09 Million - $3.54 Million	82,549 Added 1347.52%	88,675 $3.37 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $7.94 Million - $9.84 Million	-227,625 Reduced 97.38%	6,126 $231,000
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $2.86 Million - $3.99 Million	84,741 Added 56.87%	233,751 $9.91 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $2.75 Million - $32.6 Million	87,153 Added 140.89%	149,010 $4.79 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $465,607 - $669,343	-17,354 Reduced 21.91%	61,857 $2.01 Million
Q1 2022 May 16, 2022	BUY	$30.95 - $39.68 $859,914 - $1.1 Million	27,784 Added 54.03%	79,211 $2.87 Million
Q4 2021 Feb 14, 2022	SELL	$35.87 - $47.12 $401,492 - $527,414	-11,193 Reduced 17.87%	51,427 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $2.03 Million - $2.37 Million	-48,739 Reduced 43.77%	62,620 $2.74 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $2.88 Million - $3.9 Million	87,458 Added 365.92%	111,359 $4.55 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $436,095 - $626,217	14,104 Added 143.96%	23,901 $785,000
Q4 2020 Feb 16, 2021	SELL	$33.66 - $40.76 $635,500 - $769,548	-18,880 Reduced 65.84%	9,797 $398,000
Q3 2020 Nov 16, 2020	SELL	$33.07 - $38.68 $2.55 Million - $2.98 Million	-77,079 Reduced 72.88%	28,677 $1.05 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $1.76 Million - $2.98 Million	87,931 Added 493.3%	105,756 $3.58 Million
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $106,895 - $157,196	-6,233 Reduced 25.91%	17,825 $378,000
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $454,215 - $580,760	24,058 New	24,058 $537,000

Others Institutions Holding GMAB

# of Institutions

247

Shares Held

66.2M

Call Options Held

729K

Put Options Held

398K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.4B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Genmab A/S Transaction History